vs

Side-by-side financial comparison of Sphere 3D Corp. (ANY) and UNITED GUARDIAN INC (UG). Click either name above to swap in a different company.

UNITED GUARDIAN INC is the larger business by last-quarter revenue ($3.0M vs $2.7M, roughly 1.1× Sphere 3D Corp.). On growth, UNITED GUARDIAN INC posted the faster year-over-year revenue change (19.6% vs 3.1%). UNITED GUARDIAN INC produced more free cash flow last quarter ($308.0K vs $-23.6M). Over the past eight quarters, UNITED GUARDIAN INC's revenue compounded faster (-4.6% CAGR vs -37.4%).

Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.

The Guardian Life Insurance Company of America is one of the largest mutual life insurance companies in the world. Based in Manhattan, it has approximately 8,000 employees in the United States, and a network of over 3,000 financial representatives in more than 70 agencies nationwide. As of 2018, it ranks 239th on the Fortune 500 list of largest American corporations by revenue. In 2015, Guardian achieved the highest earnings in its 155-year history with $7.3 billion in capital and $1.5 billio...

ANY vs UG — Head-to-Head

Bigger by revenue
UG
UG
1.1× larger
UG
$3.0M
$2.7M
ANY
Growing faster (revenue YoY)
UG
UG
+16.5% gap
UG
19.6%
3.1%
ANY
More free cash flow
UG
UG
$23.9M more FCF
UG
$308.0K
$-23.6M
ANY
Faster 2-yr revenue CAGR
UG
UG
Annualised
UG
-4.6%
-37.4%
ANY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANY
ANY
UG
UG
Revenue
$2.7M
$3.0M
Net Profit
Gross Margin
45.0%
Operating Margin
-372.7%
24.4%
Net Margin
Revenue YoY
3.1%
19.6%
Net Profit YoY
EPS (diluted)
$-6.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANY
ANY
UG
UG
Q4 25
$2.7M
$3.0M
Q3 25
$2.6M
$2.3M
Q2 25
$3.0M
$2.8M
Q1 25
$2.8M
$2.5M
Q4 24
$2.6M
$2.5M
Q3 24
$2.4M
$3.1M
Q2 24
$4.7M
$3.4M
Q1 24
$6.9M
$3.3M
Net Profit
ANY
ANY
UG
UG
Q4 25
Q3 25
$-4.2M
$268.4K
Q2 25
$1.7M
$626.8K
Q1 25
$-8.8M
$560.9K
Q4 24
Q3 24
$104.0K
$865.5K
Q2 24
$2.1M
$956.2K
Q1 24
$-4.5M
$925.4K
Gross Margin
ANY
ANY
UG
UG
Q4 25
45.0%
Q3 25
25.4%
42.1%
Q2 25
23.8%
52.8%
Q1 25
22.1%
54.7%
Q4 24
51.7%
Q3 24
-16.0%
54.0%
Q2 24
15.2%
54.0%
Q1 24
38.0%
52.2%
Operating Margin
ANY
ANY
UG
UG
Q4 25
-372.7%
24.4%
Q3 25
-153.8%
9.5%
Q2 25
-87.0%
24.5%
Q1 25
-184.2%
24.6%
Q4 24
-328.7%
22.5%
Q3 24
-218.8%
31.0%
Q2 24
-122.4%
32.9%
Q1 24
-26.9%
31.5%
Net Margin
ANY
ANY
UG
UG
Q4 25
Q3 25
-162.0%
11.9%
Q2 25
55.2%
22.1%
Q1 25
-311.9%
22.6%
Q4 24
Q3 24
4.4%
28.3%
Q2 24
45.5%
28.2%
Q1 24
-64.5%
28.4%
EPS (diluted)
ANY
ANY
UG
UG
Q4 25
$-6.96
Q3 25
$-0.15
Q2 25
$0.06
Q1 25
$-0.32
Q4 24
$-4.62
Q3 24
$0.01
Q2 24
$0.10
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANY
ANY
UG
UG
Cash + ST InvestmentsLiquidity on hand
$3.7M
$8.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.3M
$11.2M
Total Assets
$25.1M
$13.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANY
ANY
UG
UG
Q4 25
$3.7M
$8.6M
Q3 25
$5.3M
$8.3M
Q2 25
$4.7M
$8.4M
Q1 25
$2.8M
$8.1M
Q4 24
$5.4M
$9.4M
Q3 24
$5.0M
$9.5M
Q2 24
$4.3M
$9.9M
Q1 24
$9.3M
$8.6M
Stockholders' Equity
ANY
ANY
UG
UG
Q4 25
$23.3M
$11.2M
Q3 25
$29.5M
$10.6M
Q2 25
$32.7M
$11.5M
Q1 25
$30.7M
$10.8M
Q4 24
$39.3M
$11.9M
Q3 24
$35.8M
$11.4M
Q2 24
$33.4M
$12.1M
Q1 24
$27.5M
$11.2M
Total Assets
ANY
ANY
UG
UG
Q4 25
$25.1M
$13.1M
Q3 25
$31.1M
$12.2M
Q2 25
$34.4M
$13.4M
Q1 25
$34.3M
$12.8M
Q4 24
$43.2M
$13.8M
Q3 24
$44.3M
$13.3M
Q2 24
$44.0M
$13.8M
Q1 24
$42.0M
$13.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANY
ANY
UG
UG
Operating Cash FlowLast quarter
$-16.1M
$330.5K
Free Cash FlowOCF − Capex
$-23.6M
$308.0K
FCF MarginFCF / Revenue
-867.3%
10.4%
Capex IntensityCapex / Revenue
275.4%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.5M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANY
ANY
UG
UG
Q4 25
$-16.1M
$330.5K
Q3 25
$-3.5M
$1.0M
Q2 25
$-5.8M
$303.2K
Q1 25
$-4.1M
$322.1K
Q4 24
$-4.6M
$269.3K
Q3 24
$290.0K
$1.2M
Q2 24
$-3.3M
$1.3M
Q1 24
$-58.0K
$644.1K
Free Cash Flow
ANY
ANY
UG
UG
Q4 25
$-23.6M
$308.0K
Q3 25
$-5.7M
$995.8K
Q2 25
$-6.0M
$285.6K
Q1 25
$-5.1M
$318.5K
Q4 24
$-13.5M
$-45.9K
Q3 24
$-4.3M
$1.2M
Q2 24
$1.3M
Q1 24
$622.2K
FCF Margin
ANY
ANY
UG
UG
Q4 25
-867.3%
10.4%
Q3 25
-218.7%
44.0%
Q2 25
-200.5%
10.1%
Q1 25
-181.2%
12.8%
Q4 24
-511.9%
-1.9%
Q3 24
-184.4%
39.2%
Q2 24
37.1%
Q1 24
19.1%
Capex Intensity
ANY
ANY
UG
UG
Q4 25
275.4%
0.8%
Q3 25
86.5%
0.7%
Q2 25
6.6%
0.6%
Q1 25
36.4%
0.1%
Q4 24
338.7%
12.7%
Q3 24
196.7%
1.0%
Q2 24
0.0%
1.9%
Q1 24
0.0%
0.7%
Cash Conversion
ANY
ANY
UG
UG
Q4 25
Q3 25
3.77×
Q2 25
-3.51×
0.48×
Q1 25
0.57×
Q4 24
Q3 24
2.79×
1.42×
Q2 24
-1.55×
1.38×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANY
ANY

Segment breakdown not available.

UG
UG

Pharmaceuticals$1.6M53%
Other$1.4M47%

Related Comparisons